1Davi G,Tuttolomondo A,Santilli F,et al.CD40 ligand and MCP-1 as pre-dictors of cardiovascular events in diabetic patients with stroke(J).J Ath-eroscler Thromb,2009;16(6):707-13.
2Ferroni P,Santilli F,Guadagni F,et al.Contribution of platelet-derived CD40 ligand to inflammation,thrombosis and neoangiogenesis(J).Cur Med Chem,2007;14(20):2170-80.
3Packard RR,Libby P.Inflammation in atherosclerosis:from vascular biol-ogy to biomarker discovery and risk prediction(J).Clin Chem,2008;54(1):24-8.
4DavìG,Patrono C.Platelet activation and atherothrombosis(J).Engl J Med,2007;357(24):2482-94.
5Santill F,Basili S,Ferron P,et al.CD40/CD40L system and vascular dis-ease(J).Int Emerg Med,2007;2(4):256-68.
10Lobbes MB,Lutgens E,Heeneman S,et al.Is there more than C-reactive protein and fibrinogen?The prognostic value of soluble CD40 ligand,inter-leukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease(J).Atherosclerosis,2006;187(1):18-25.
